Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$18.67 - $24.56 $6.71 Million - $8.83 Million
359,422 Added 42.62%
1,202,733 $29.3 Million
Q4 2022

Feb 14, 2023

SELL
$17.24 - $23.95 $14.5 Million - $20.1 Million
-839,924 Reduced 49.9%
843,311 $18.1 Million
Q3 2022

Nov 14, 2022

BUY
$9.4 - $18.59 $11.1 Million - $21.9 Million
1,180,342 Added 234.71%
1,683,235 $30.2 Million
Q2 2022

Aug 15, 2022

BUY
$9.12 - $18.9 $4.59 Million - $9.5 Million
502,893 New
502,893 $4.84 Million
Q1 2022

May 16, 2022

SELL
$12.15 - $16.83 $408,580 - $565,959
-33,628 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$13.83 - $18.78 $465,075 - $631,533
33,628 New
33,628 $562,000

Others Institutions Holding ISEE

About IVERIC bio, Inc.


  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.